Arteriovenous Malformations Market is segmented By Treatment (Surgical Removal, Endovascular Emboliz...
Market Size in USD Bn
CAGR7.00%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 7.00% |
Market Concentration | Medium |
Major Players | Medtronic, Johnson & Johnson, Stryker Corporation, Penumbra Inc., MicroVention, Inc. and Among Others |
The arteriovenous malformations market is estimated to be valued at USD 3.36 Bn in 2025 and is expected to reach USD 4.99 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.00% from 2025 to 2032. Growing adoption of gamma knife radiosurgery and endovascular embolization is expected to drive the demand. Moreover, increasing healthcare expenditure and availability of advanced treatment options in developing nations will further aid the arteriovenous malformations market expansion over the forecast period.